C09982672 / invoice 10000
Species:CANINE
Breed:French Bulldog
Age (years):5
Diagnosis or signs:Meds review
Consult notes
Animal clinical history (3 most recent)
2026-03-04T00:00:00Z 12:00 AM
Reason: Meds Review & Bloods (JB)Appointment Notes: Overdue reminders ------- Sms reply: YHISTORY: Presented for a medication review for ongoing use of Apoquel. The owner reports good response to treatment, with licking of paws controlled as long as the medication is administered consistently at a dose of half a tablet daily. No other concerns reported.Current meds: Apoquel 16mg half a tablet daily.Vaccination: C5 UTDParasite Prevention: UTD with unknown brandPre-existing conditions: Atopic dermatitis (licking paws) when apoquel stopped.Access to toxins eg. Rodenticide: none EXAMINATION:Body Condition Score: Overweight 6/9.Pain Scale (0-4): 0/4Hydration status (%): hydration clinically adequateCardiovascular: cardiac auscultation normal, normal rhythm, pulse pressures normal and synchronousRespiratory: thoracic auscultation clear sounds bilaterally, respiratory effort normal, no nasal dischargeNeurological: neurologically no significant findingsMusculoskeletal: ambulating normally, no palpable neck, spine, limb or joint painGastrointestinal:- Oral: normal, no mouth pain, dental score (1-4): 0- Abdominal: no detectable pain on abdominal palpation- Rectal: not performedUrinary: NSFReproductive: NSFIntegument/Ears: NSFLymph Nodes: NSFEyes: NSFDemeanour/Behaviour: not discussed PROBLEM LIST:- Chronic atopic dermatitis managed with Apoquel.- Overweight body condition. DIFFERENTIAL DIAGNOSIS/ DIAGNOSIS:Atopic dermatitis. DIAGNOSTICS:Bloods were taken for IDEXX TAHP testing:- Please find attached to the patient record.> Complete Blood Count- Significant findings: To be reviewed. > Biochemistry- Significant findings: To be reviewed. ASSESSMENT: Presented for a medication review while on long-term Apoquel. Clinically well. Examination revealed an overweight body condition. Bloods collected for routine monitoring due to long-term immunomodulatory medication use to assess for any changes, particularly hepatic or immune-related parameters. TREATMENT: Bloods collected for in-house CBC and biochemistry analysis for chronic using aoquel PLAN:1. Pend and Review blood results.2. Continue Apoquel as directed.3. Discuss weight management plan with owner. Suggest to put on diet/minimise high calories treats- Home into owner's care. CLIENT COMMUNICATION:Discussed the rationale for performing a blood test to monitor for any potential side effects from the long-term use of Apoquel. Also briefly mentioned the patient being overweight. Awaiting blood results for further discussion.Consent has been given by the client to proceed with this treatment - Yes Vital Signs Weight: 17.8; HeartRate: 80; DentalGrade: 0; RespirationRate: panting; CRT: 2; MMColour: pink; BodyScore: 6;
Previous claim history (11)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2025-04-22 | C8609270 | ALLERGY |
| 2025-03-24 | C8491660 | ALLERGY |
| 2023-02-22 | C5616633 | PATELLA LUXATION - MEDIAL |
| 2022-05-19 | C4826888 | PNEUMONIA - ASPIRATION |
| 2021-09-29 | C4159507 | MISCELLANEOUS CONDITIONS |
| 2021-07-27 | C3937192 | DESEXING |
| 2021-07-27 | C3937192 | HEARTWORM TEST OR BLOOD SCREEN |
| 2021-07-27 | C3937192 | PRESCRIPTION DIETS |
| 2021-04-25 | C3696578 | INGEST FOREIGN OBJECT |
| 2021-04-25 | C3696704 | INGEST FOREIGN OBJECT |
| 2021-04-25 | C5335689 | INGEST FOREIGN OBJECT |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_diagnostic_test_-_blood_test | 233.01 | 2026-03-04 | — |
| 20000 | tstarc_consultation-revisit | 7.30 | 2026-03-04 | — |
| 30000 | tstarc_consultation-revisit | 80.40 | 2026-03-04 | — |
| 40000 | tstarc_consultation-revisit | 18.29 | 2026-03-04 | — |
UPM+
- DG02319HYPERSENSITIVITY (ALLERGIC) SKIN DISORDERDSTP_skin_-_allergic_disorder
Variant (sleepy_king)
HYPERSENSITIVITY DISORDER (ALLERGY)
DSTP_skin_-_allergic_disorder
Conf: 0.870
Threshold: 0.38
Above: ✓
Correct?